Pharmacists in Inchelium, WA Accepting Medicare
4 Pharmacists found. Showing 1 - 4
 Mr. Thomas Richard Berg, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39 Shortcut Road, Inchelium, WA 99138 Phone: 509-722-7009 Fax: 509-722-7021 |
 Dr. Kim Rosenthal, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39 Shortcut Road, Inchelium, WA 99138 Phone: 509-722-7007 |
Kimberly Ann Walters, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39 Shortcut Road, Inchelium, WA 99138 Phone: 509-722-7007 Fax: 509-722-7632 |
Jeremiah Johnson Salmond, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 39 Shortcut Rd, Inchelium, WA 99138 Phone: 509-722-7007 Fax: 509-722-7632 |
News Archive
First Edition: May 21, 2013
Today's headlines include stories examining how the approaching implementation of some health law provisions is highlighting key policy questions.
Orlistat, a drug that decreases fat absorption, appears helpful for improving weight management in obese adolescents
When combined with diet, exercise and behavioral therapy, orlistat, a drug that decreases fat absorption, appears helpful for improving weight management in obese adolescents, compared with placebo, according to an article in the June 15 issue of JAMA: The Journal of the American Medical Association.
Experian to acquire Medical Present Value
Experian, the leading global information services company, today announced that it has signed a definitive agreement to acquire Medical Present Value, Inc., a leading provider of revenue cycle management software, data and analytics to more than 75,000 U.S. physicians.
Expanding health centers to reach more patients will result in huge health care savings
Expanding health centers to reach an additional 20 million patients as part of national health reform would result in overall health care savings of $212 billion over the ten-year period 2010 to 2019, including federal Medicaid savings of $59 billion.
Sanofi-aventis, Sunnybrook enter agreement to develop and commercialize vasculotide
Sanofi-aventis and Sunnybrook Health Sciences Centre announced that they have entered into a research agreement and licensing option for vasculotide, an investigational compound to treat chronic wounds. This includes neuropathic diabetic foot ulcers caused by a lack of sensation and neuropathic ulcers that are complicated by peripheral arterial disease, commonly called neuroischemic diabetic foot ulcers.
› Verified 4 days ago